SEC
|
Wettig Thane
|
CEO
|
|
+145K
|
$0.35
|
+$50.75K
|
|
SEC
|
Schoeneck James A
|
N/A
|
|
+300K
|
$0.35
|
+$105.00K
|
|
SEC
|
Adib Deyaa
|
Chief Medical Officer
|
|
+22K
|
$1.17
|
+$25.88K
|
|
SEC
|
Wettig Thane
|
CEO
|
|
+50K
|
$1.91
|
+$95.50K
|
|
SEC
|
Wettig Thane
|
Chief Commercial Officer
|
|
-734
|
$15.80
|
-$11.60K
|
|
SEC
|
Graham Juan
|
Chief Financial Officer
|
|
-2.2K
|
$14.64
|
-$32.03K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-1.1K
|
$15.79
|
-$17.31K
|
|
SEC
|
Conterno Enrique A
|
Chief Executive Officer
|
|
-2.5K
|
$15.79
|
-$40.15K
|
|
SEC
|
Graham Juan
|
Chief Financial Officer
|
|
-5.7K
|
$14.89
|
-$85.48K
|
|
SEC
|
Wettig Thane
|
Chief Commercial Officer
|
|
-382
|
$15.79
|
-$6.03K
|
|
SEC
|
Eisner Mark
|
Chief Medical Officer
|
|
-1.1K
|
$15.04
|
-$16.30K
|
|
SEC
|
Conterno Enrique A
|
Chief Executive Officer
|
|
-1.3K
|
$14.26
|
-$18.48K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-4.7K
|
$13.01
|
-$60.93K
|
|
SEC
|
Eisner Mark
|
Chief Medical Officer
|
|
-6.8K
|
$13.01
|
-$88.17K
|
|
SEC
|
Wettig Thane
|
Chief Commercial Officer
|
|
-655
|
$12.26
|
-$8.03K
|
|
SEC
|
Graham Juan
|
Chief Financial Officer
|
|
-3K
|
$12.62
|
-$37.97K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-518
|
$12.26
|
-$6.35K
|
|
SEC
|
Conterno Enrique A
|
Chief Executive Officer
|
|
-1.8K
|
$12.26
|
-$21.72K
|
|
SEC
|
Wettig Thane
|
Chief Commercial Officer
|
|
-360
|
$12.26
|
-$4.41K
|
|
SEC
|
Eisner Mark
|
Chief Medical Officer
|
|
-756
|
$13.09
|
-$9.90K
|
|
SEC
|
Conterno Enrique A
|
Chief Executive Officer
|
|
-1.3K
|
$12.40
|
-$16.07K
|
|
SEC
|
Wettig Thane
|
Chief Commercial Officer
|
|
-655
|
$11.42
|
-$7.48K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-1.9K
|
$9.50
|
-$17.58K
|
|
SEC
|
Conterno Enrique A
|
Chief Executive Officer
|
|
-1.8K
|
$9.50
|
-$16.83K
|
|
SEC
|
Wettig Thane
|
Chief Commercial Officer
|
|
-720
|
$9.50
|
-$6.84K
|
|
SEC
|
Eisner Mark
|
Chief Medical Officer
|
|
-1.1K
|
$9.61
|
-$10.97K
|
|
SEC
|
Conterno Enrique A
|
Chief Executive Officer
|
|
-1.3K
|
$12.73
|
-$16.69K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-4.7K
|
$12.02
|
-$56.28K
|
|
SEC
|
Eisner Mark
|
Chief Medical Officer
|
|
-6.4K
|
$12.02
|
-$77.43K
|
|
SEC
|
Wettig Thane
|
Chief Commercial Officer
|
|
-655
|
$13.31
|
-$8.72K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-3.9K
|
$12.69
|
-$49.55K
|
|
SEC
|
Conterno Enrique A
|
Chief Executive Officer
|
|
-7.1K
|
$12.69
|
-$89.86K
|
|
SEC
|
Wettig Thane
|
Chief Commercial Officer
|
|
-1.7K
|
$12.69
|
-$21.65K
|
|
SEC
|
Eisner Mark
|
Chief Medical Officer
|
|
-756
|
$13.62
|
-$10.30K
|
|
SEC
|
Conterno Enrique A
|
Chief Executive Officer
|
|
-1.5K
|
$13.93
|
-$21.40K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-5.3K
|
$14.82
|
-$78.31K
|
|
SEC
|
Eisner Mark
|
Chief Medical Officer
|
|
-7K
|
$14.82
|
-$104.38K
|
|
SEC
|
Wettig Thane
|
Chief Commercial Officer
|
|
-517
|
$14.97
|
-$7.74K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-2.7K
|
$14.19
|
-$37.86K
|
|
SEC
|
Eisner Mark
|
Chief Medical Officer
|
|
-4.3K
|
$12.65
|
-$54.88K
|
|
SEC
|
Conterno Enrique A
|
Chief Executive Officer
|
|
-1.9K
|
$10.20
|
-$18.96K
|
|
SEC
|
Wettig Thane
|
Chief Commercial Officer
|
|
-620
|
$10.18
|
-$6.31K
|
|
SEC
|
KEARNS THOMAS F JR
|
N/A
|
|
-13K
|
$11.58
|
-$151.70K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-2K
|
$12.41
|
-$25.19K
|
|
SEC
|
Cotroneo Pat
|
Executive Advisor & Former CFO
|
|
-2.1K
|
$12.41
|
-$26.57K
|
|
SEC
|
Wettig Thane
|
Chief Commercial Officer
|
|
+3.1K
|
$11.53
|
+$35.74K
|
|
SEC
|
Conterno Enrique A
|
Chief Executive Officer
|
|
-1.9K
|
$25.06
|
-$46.59K
|
|
SEC
|
Wettig Thane
|
Chief Commercial Officer
|
|
-2.6K
|
$27.65
|
-$71.70K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-4.1K
|
$25.62
|
-$103.84K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-2K
|
$22.90
|
-$46.49K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-2.1K
|
$22.90
|
-$49.03K
|
|
SEC
|
KEARNS THOMAS F JR
|
N/A
|
|
-18K
|
$35.02
|
-$630.36K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-5.7K
|
$33.37
|
-$189.51K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-5.7K
|
$33.37
|
-$188.77K
|
|
SEC
|
Kouchakji Elias
|
SVP, Clinical Dev, Drug Safety
|
|
-5.2K
|
$33.37
|
-$174.22K
|
|
SEC
|
Conterno Enrique A
|
Chief Executive Officer
|
|
-5.4K
|
$38.31
|
-$207.30K
|
|
SEC
|
Schoeneck James A
|
N/A
|
|
+6K
|
$9.78
|
+$58.68K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-3.4K
|
$41.61
|
-$139.39K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-3.1K
|
$43.60
|
-$133.76K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-3K
|
$41.99
|
-$127.61K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-3K
|
$41.99
|
-$126.56K
|
|
SEC
|
Kouchakji Elias
|
SVP, Clinical Dev, Drug Safety
|
|
-2.7K
|
$41.99
|
-$114.55K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-3.3K
|
$41.99
|
-$138.23K
|
|
SEC
|
Kouchakji Elias
|
SVP, Clinical Dev, Drug Safety
|
|
+7.1K
|
$14.58
|
+$103.26K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-3.4K
|
$44.01
|
-$147.48K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-3.1K
|
$43.63
|
-$133.94K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-3K
|
$42.16
|
-$128.08K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-3K
|
$42.16
|
-$127.07K
|
|
SEC
|
Kouchakji Elias
|
SVP, Clinical Dev, Drug Safety
|
|
-2.7K
|
$42.16
|
-$115.01K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-3.3K
|
$42.16
|
-$138.75K
|
|
SEC
|
Schoeneck James A
|
N/A
|
|
+6K
|
$5.95
|
+$35.70K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
+7.3K
|
$31.62
|
+$229.25K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-3.4K
|
$42.35
|
-$141.91K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-3.9K
|
$39.68
|
-$155.86K
|
|
SEC
|
Conterno Enrique A
|
Chief Executive Officer
|
|
+28K
|
$35.57
|
+$988.85K
|
|
SEC
|
Rosenkranz Roberto Pedro
|
N/A
|
|
+24K
|
$23.85
|
+$572.40K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-3K
|
$33.61
|
-$102.11K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-2.2K
|
$33.61
|
-$72.46K
|
|
SEC
|
Kouchakji Elias
|
SVP, Clinical Dev, Drug Safety
|
|
-2.7K
|
$33.61
|
-$91.69K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-3.3K
|
$33.61
|
-$110.64K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
+26K
|
$12.82
|
+$338.05K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
+26K
|
$8.08
|
+$209.11K
|
|
SEC
|
Kouchakji Elias
|
SVP, Clinical Dev, Drug Safety
|
|
+31K
|
$5.89
|
+$182.44K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
+39K
|
$7.90
|
+$307.50K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-11K
|
$42.87
|
-$482.29K
|
|
SEC
|
Kurkijarvi Kalevi
|
N/A
|
|
-6K
|
$42.66
|
-$255.96K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-3.2K
|
$27.27
|
-$87.32K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-3.5K
|
$38.21
|
-$133.93K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-3.4K
|
$46.68
|
-$159.65K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-3.5K
|
$47.39
|
-$164.87K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-3.1K
|
$47.39
|
-$148.99K
|
|
SEC
|
Kouchakji Elias
|
SVP, Clinical Dev, Drug Safety
|
|
-2.4K
|
$47.39
|
-$115.73K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
+797
|
$30.84
|
+$24.58K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
+13K
|
$2.90
|
+$36.25K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-3.5K
|
$31.69
|
-$111.07K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-3.2K
|
$41.38
|
-$132.46K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-3.4K
|
$40.92
|
-$139.91K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-8.4K
|
$41.68
|
-$351.65K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-3.1K
|
$41.68
|
-$131.04K
|
|
SEC
|
Kouchakji Elias
|
SVP, Clinical Dev, Drug Safety
|
|
-5.5K
|
$41.68
|
-$230.95K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-8.3K
|
$41.68
|
-$346.65K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-26K
|
$33.70
|
-$875.12K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-26K
|
$34.53
|
-$896.68K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-26K
|
$35.50
|
-$921.86K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-26K
|
$34.19
|
-$887.85K
|
|
SEC
|
Kouchakji Elias
|
SVP, Clinical Dev, Drug Safety
|
|
-2.9K
|
$45.00
|
-$129.29K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-26K
|
$33.61
|
-$872.78K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-3.5K
|
$38.18
|
-$133.82K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-3.2K
|
$43.12
|
-$138.03K
|
|
SEC
|
Kouchakji Elias
|
SVP, Clinical Dev, Drug Safety
|
|
+16K
|
$14.58
|
+$233.28K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
+7.3K
|
$20.97
|
+$152.62K
|
|
SEC
|
Chung Christine
|
SVP, China Operations
|
|
-3.5K
|
$38.31
|
-$133.32K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-3.1K
|
$38.31
|
-$120.45K
|
|
SEC
|
Kouchakji Elias
|
SVP, Clinical Dev, Drug Safety
|
|
-2.1K
|
$38.31
|
-$78.84K
|
|
SEC
|
Kurkijarvi Kalevi
|
N/A
|
|
+4.7K
|
$14.64
|
+$68.81K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-35K
|
$30.42
|
-$1.05M
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-3.4K
|
$38.31
|
-$128.72K
|
|
SEC
|
Schoeneck James A
|
N/A
|
|
+14K
|
$3.41
|
+$47.74K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-26K
|
$27.05
|
-$702.43K
|
|
SEC
|
Rosenkranz Roberto Pedro
|
N/A
|
|
+30K
|
$16.49
|
+$494.70K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-26K
|
$27.77
|
-$721.13K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
+7K
|
$2.90
|
+$20.30K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-26K
|
$35.52
|
-$922.38K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
+10K
|
$2.90
|
+$29.00K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-26K
|
$40.95
|
-$1.06M
|
|
SEC
|
Routti Jorma
|
N/A
|
|
+30K
|
$22.75
|
+$682.50K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-26K
|
$42.03
|
-$1.09M
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-7.7K
|
$55.41
|
-$424.72K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-9.1K
|
$56.30
|
-$514.86K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-26K
|
$42.13
|
-$1.09M
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-5.9K
|
$55.94
|
-$332.00K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-17K
|
$55.99
|
-$970.70K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-5.6K
|
$55.96
|
-$315.50K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-19K
|
$38.98
|
-$740.54K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-28K
|
$40.61
|
-$1.12M
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-39K
|
$39.61
|
-$1.56M
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-9.1K
|
$25.67
|
-$233.29K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-3.3K
|
$41.10
|
-$136.86K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-3.4K
|
$38.58
|
-$132.02K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-3.3K
|
$41.84
|
-$136.82K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-28K
|
$32.80
|
-$907.18K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-3.4K
|
$41.82
|
-$140.60K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-19K
|
$27.12
|
-$515.23K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-19K
|
$30.38
|
-$577.16K
|
|
SEC
|
Schoeneck James A
|
N/A
|
|
+24K
|
$13.89
|
+$333.36K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-19K
|
$36.89
|
-$700.84K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-19K
|
$40.13
|
-$762.35K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-19K
|
$39.24
|
-$745.40K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
+8.2K
|
$13.14
|
+$107.51K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-1K
|
$57.35
|
-$57.98K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-19K
|
$39.05
|
-$741.79K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-3.3K
|
$58.44
|
-$191.16K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-8.7K
|
$58.29
|
-$504.73K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-2.4K
|
$57.30
|
-$135.69K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
+5.8K
|
$18.51
|
+$107.47K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-19K
|
$40.85
|
-$775.99K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-19K
|
$42.66
|
-$810.37K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-19K
|
$43.92
|
-$834.30K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-19K
|
$43.97
|
-$835.25K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-19K
|
$43.07
|
-$818.16K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-2.3K
|
$44.65
|
-$103.54K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-3.4K
|
$59.20
|
-$202.58K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-3.3K
|
$56.28
|
-$185.05K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-6.4K
|
$56.60
|
-$360.71K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-2.4K
|
$56.60
|
-$134.09K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-21K
|
$37.92
|
-$807.05K
|
|
SEC
|
Cotroneo Pat
|
SVP, Finance and CFO
|
|
-993
|
$38.55
|
-$38.28K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-993
|
$54.05
|
-$53.67K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-19K
|
$35.31
|
-$670.75K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-19K
|
$32.16
|
-$610.91K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
+34K
|
$2.90
|
+$97.30K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-19K
|
$33.16
|
-$629.91K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-7.5K
|
$47.81
|
-$358.58K
|
|
SEC
|
Routti Jorma
|
N/A
|
|
-6K
|
$46.59
|
-$279.54K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-19K
|
$31.21
|
-$592.87K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-22K
|
$36.12
|
-$778.46K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-42K
|
$52.85
|
-$2.22M
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
+22K
|
$12.56
|
+$277.69K
|
|
SEC
|
RIGGS RORY B
|
N/A
|
|
-32K
|
$54.66
|
-$1.75M
|
|
SEC
|
Tamura Toshinari
|
N/A
|
|
-24K
|
$53.37
|
-$1.28M
|
|
SEC
|
KEARNS THOMAS F JR
|
N/A
|
|
-500
|
$28.90
|
-$14.45K
|
|
SEC
|
RIGGS RORY B
|
N/A
|
|
-23K
|
$55.75
|
-$1.28M
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-7.7K
|
$53.45
|
-$412.95K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-35K
|
$39.60
|
-$1.40M
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-5.1K
|
$53.55
|
-$271.23K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-1.9K
|
$54.95
|
-$102.21K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-4.5K
|
$54.95
|
-$244.80K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-1.3K
|
$54.95
|
-$71.27K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-19K
|
$38.13
|
-$728.51K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-7.5K
|
$53.97
|
-$404.78K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-39K
|
$61.40
|
-$2.37M
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-10K
|
$62.00
|
-$620.00K
|
|
SEC
|
Rosenkranz Roberto Pedro
|
N/A
|
|
-6K
|
$60.00
|
-$360.00K
|
|
SEC
|
Rosenkranz Roberto Pedro
|
N/A
|
|
-2K
|
$50.00
|
-$100.00K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-39K
|
$47.46
|
-$1.83M
|
|
SEC
|
Kurkijarvi Kalevi
|
N/A
|
|
-12K
|
$25.14
|
-$301.68K
|
|
SEC
|
Rosenkranz Roberto Pedro
|
N/A
|
|
-5K
|
$42.07
|
-$210.35K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-39K
|
$47.61
|
-$1.84M
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-40K
|
$47.16
|
-$1.87M
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
+41K
|
$16.74
|
+$692.43K
|
|
SEC
|
Kurkijarvi Kalevi
|
N/A
|
|
-2K
|
$42.80
|
-$85.60K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-39K
|
$42.19
|
-$1.63M
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-2.9K
|
$43.70
|
-$124.59K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-2.9K
|
$46.00
|
-$131.15K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-1.2K
|
$44.85
|
-$51.62K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-3.3K
|
$44.85
|
-$146.26K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-1.2K
|
$44.85
|
-$51.62K
|
|
SEC
|
Lema Gerald
|
N/A
|
|
+3.5K
|
$46.70
|
+$163.45K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-2K
|
$47.15
|
-$92.32K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-4.7K
|
$47.15
|
-$221.09K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-2K
|
$47.15
|
-$92.32K
|
|
SEC
|
Kurkijarvi Kalevi
|
N/A
|
|
-2K
|
$46.65
|
-$93.30K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-39K
|
$46.63
|
-$1.80M
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
+32K
|
$2.90
|
+$93.98K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-7.5K
|
$55.37
|
-$415.28K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-39K
|
$56.13
|
-$2.17M
|
|
SEC
|
Kurkijarvi Kalevi
|
N/A
|
|
-2K
|
$52.24
|
-$104.48K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-39K
|
$55.02
|
-$2.13M
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-39K
|
$55.09
|
-$2.13M
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-10K
|
$37.46
|
-$374.60K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-39K
|
$53.46
|
-$2.07M
|
|
SEC
|
Kurkijarvi Kalevi
|
N/A
|
|
-4K
|
$46.65
|
-$186.60K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-39K
|
$51.67
|
-$2.00M
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-2.9K
|
$51.00
|
-$145.40K
|
|
SEC
|
RIGGS RORY B
|
N/A
|
|
-25K
|
$51.92
|
-$1.30M
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-2.9K
|
$49.45
|
-$140.98K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-3.1K
|
$48.67
|
-$151.36K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-7.9K
|
$48.63
|
-$386.56K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-3.1K
|
$48.67
|
-$151.36K
|
|
SEC
|
Routti Jorma
|
N/A
|
|
-12K
|
$47.36
|
-$568.32K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-2.2K
|
$23.65
|
-$52.31K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-7.5K
|
$41.03
|
-$307.73K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-18K
|
$38.06
|
-$666.05K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-836
|
$18.90
|
-$15.80K
|
|
SEC
|
Kurkijarvi Kalevi
|
N/A
|
|
-2K
|
$33.45
|
-$66.90K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-5K
|
$32.98
|
-$164.90K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-836
|
$18.03
|
-$15.07K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-836
|
$17.09
|
-$14.29K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-8K
|
$17.44
|
-$140.34K
|
|
SEC
|
Kurkijarvi Kalevi
|
N/A
|
|
-2K
|
$28.50
|
-$57.00K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-3.7K
|
$28.95
|
-$107.72K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-2.9K
|
$28.75
|
-$83.12K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-1.2K
|
$29.05
|
-$33.44K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-3.3K
|
$29.05
|
-$94.73K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-829
|
$29.05
|
-$24.08K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
+8.1K
|
$6.88
|
+$55.60K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-5.5K
|
$15.17
|
-$83.81K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-1.4K
|
$27.60
|
-$38.92K
|
|
SEC
|
Kurkijarvi Kalevi
|
N/A
|
|
-2K
|
$27.40
|
-$54.80K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-836
|
$15.16
|
-$12.67K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-5K
|
$26.38
|
-$131.90K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-836
|
$15.38
|
-$12.86K
|
|
SEC
|
Kurkijarvi Kalevi
|
N/A
|
|
-2K
|
$25.25
|
-$50.50K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-836
|
$14.52
|
-$12.14K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-836
|
$14.08
|
-$11.77K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-836
|
$14.29
|
-$11.95K
|
|
SEC
|
Kurkijarvi Kalevi
|
N/A
|
|
-2K
|
$25.20
|
-$50.40K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-17K
|
$17.50
|
-$296.10K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-7.9K
|
$25.41
|
-$199.49K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-7.9K
|
$25.30
|
-$198.63K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
+34K
|
$2.79
|
+$93.49K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
+88K
|
$3.64
|
+$320.19K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
+36K
|
$2.61
|
+$95.13K
|
|
SEC
|
Kurkijarvi Kalevi
|
N/A
|
|
-2K
|
$24.45
|
-$48.90K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-836
|
$14.09
|
-$11.78K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-9.6K
|
$15.16
|
-$145.78K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-9.6K
|
$15.06
|
-$144.82K
|
|
SEC
|
Kurkijarvi Kalevi
|
N/A
|
|
-2K
|
$24.90
|
-$49.80K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-38K
|
$23.85
|
-$901.48K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-6.5K
|
$24.00
|
-$156.00K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-5K
|
$23.56
|
-$117.80K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-38K
|
$20.74
|
-$783.93K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
+25K
|
$4.03
|
+$100.12K
|
|
SEC
|
RIGGS RORY B
|
N/A
|
|
-20K
|
$20.87
|
-$417.40K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-2.3K
|
$20.65
|
-$48.40K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-38K
|
$21.24
|
-$802.83K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-2.3K
|
$22.05
|
-$51.69K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-38K
|
$22.80
|
-$861.79K
|
|
SEC
|
KEARNS THOMAS F JR
|
N/A
|
|
-18K
|
$22.40
|
-$403.20K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-38K
|
$22.29
|
-$842.52K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-38K
|
$16.76
|
-$633.49K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-38K
|
$17.75
|
-$670.91K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-38K
|
$20.61
|
-$779.02K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-38K
|
$21.66
|
-$818.70K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-2.3K
|
$18.66
|
-$43.76K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-2.3K
|
$18.22
|
-$42.73K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-38K
|
$18.99
|
-$717.78K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-38K
|
$17.80
|
-$672.80K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-38K
|
$18.38
|
-$694.73K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$17.50
|
-$472.50K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$16.02
|
-$432.54K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-1.8K
|
$16.49
|
-$29.62K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$16.48
|
-$444.96K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-2.3K
|
$17.96
|
-$42.10K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$18.99
|
-$512.73K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$17.68
|
-$477.36K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-6.1K
|
$17.60
|
-$107.48K
|
|
SEC
|
Yu K Peony
|
Chief Medical Officer
|
|
-6.1K
|
$17.60
|
-$107.48K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$17.78
|
-$480.06K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$19.98
|
-$539.46K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$21.11
|
-$569.97K
|
|
SEC
|
VALONE FRANK H MD
|
Chief Medical Officer
|
|
-11K
|
$21.11
|
-$226.93K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$18.74
|
-$505.98K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$19.62
|
-$529.74K
|
|
SEC
|
VALONE FRANK H MD
|
Chief Medical Officer
|
|
-11K
|
$16.84
|
-$181.03K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$19.11
|
-$515.97K
|
|
SEC
|
VALONE FRANK H MD
|
Chief Medical Officer
|
|
-11K
|
$18.41
|
-$197.91K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$15.31
|
-$413.37K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$19.41
|
-$524.07K
|
|
SEC
|
KEARNS THOMAS F JR
|
N/A
|
|
-1.6K
|
$22.08
|
-$34.71K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$23.69
|
-$639.63K
|
|
SEC
|
KEARNS THOMAS F JR
|
N/A
|
|
-7.8K
|
$30.88
|
-$240.86K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$30.10
|
-$812.70K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-837
|
$28.95
|
-$24.23K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$29.59
|
-$798.93K
|
|
SEC
|
Yu K Peony
|
VP, Clinical Development
|
|
-1.1K
|
$28.96
|
-$31.65K
|
|
SEC
|
MADERO MIGUEL
|
N/A
|
|
-40K
|
$30.49
|
-$1.23M
|
|
SEC
|
Yu K Peony
|
VP, Clinical Development
|
|
-5K
|
$30.00
|
-$150.00K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-5K
|
$30.00
|
-$150.00K
|
|
SEC
|
KEARNS THOMAS F JR
|
N/A
|
|
-7.8K
|
$28.51
|
-$222.38K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$28.49
|
-$769.23K
|
|
SEC
|
Yu K Peony
|
VP, Clinical Development
|
|
-5K
|
$28.00
|
-$140.00K
|
|
SEC
|
Yu K Peony
|
VP, Clinical Development
|
|
-5K
|
$25.62
|
-$128.10K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$24.06
|
-$649.62K
|
|
SEC
|
KEARNS THOMAS F JR
|
N/A
|
|
-7.8K
|
$23.83
|
-$185.87K
|
|
SEC
|
VALONE FRANK H MD
|
Chief Medical Officer
|
|
-10K
|
$23.00
|
-$230.00K
|
|
SEC
|
Yu K Peony
|
VP, Clinical Development
|
|
-5K
|
$24.00
|
-$120.00K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$21.86
|
-$590.22K
|
|
SEC
|
Yu K Peony
|
VP, Clinical Development
|
|
-5K
|
$21.46
|
-$107.30K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$21.59
|
-$582.93K
|
|
SEC
|
VALONE FRANK H MD
|
Chief Medical Officer
|
|
-10K
|
$21.38
|
-$213.80K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$29.10
|
-$785.70K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-1.1K
|
$27.95
|
-$30.55K
|
|
SEC
|
RIGGS RORY B
|
N/A
|
|
-50K
|
$27.61
|
-$1.38M
|
|
SEC
|
MADERO MIGUEL
|
N/A
|
|
-21K
|
$27.66
|
-$569.80K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-7.5K
|
$27.33
|
-$204.98K
|
|
SEC
|
Yu K Peony
|
VP, Clinical Development
|
|
-1.1K
|
$27.84
|
-$30.43K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-14K
|
$22.88
|
-$308.88K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-14K
|
$22.92
|
-$309.42K
|
|
SEC
|
VALONE FRANK H MD
|
Chief Medical Officer
|
|
-10K
|
$23.58
|
-$235.80K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$23.32
|
-$629.64K
|
|
SEC
|
VALONE FRANK H MD
|
Chief Medical Officer
|
|
-10K
|
$23.37
|
-$233.70K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$24.71
|
-$667.17K
|
|
SEC
|
Cotroneo Pat
|
VP, Finance and CFO
|
|
-7.9K
|
$23.47
|
-$184.97K
|
|
SEC
|
VALONE FRANK H MD
|
Chief Medical Officer
|
|
-1K
|
$23.70
|
-$23.70K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$22.11
|
-$596.97K
|
|
SEC
|
Yu K Peony
|
VP, Clinical Development
|
|
-5.4K
|
$22.69
|
-$122.09K
|
|
SEC
|
Neff Thomas B
|
Chief Executive Officer
|
|
-27K
|
$23.57
|
-$636.39K
|
|